Key Takeaways
- The US Dollar Index (DXY) fell to a three-week low of 100.60 as signs of de-escalation in the US-Iran conflict dampened safe-haven demand, while global equities in Korea and Singapore surged to record levels.
- China successfully recovered the first-stage booster of its Long March 10B rocket for the first time via a sea-based "wire-net" system, marking a critical breakthrough in its race to match SpaceX (private) in reusable launch technology.
- Citigroup (C) launched a 24/7 USD clearing service using Citi Token Services in partnership with Siam Commercial Bank, enabling real-time cross-border payments even during weekends and holidays.
- HSBC (HSBC) and UBS (UBS) are leading a retreat from risky private credit, with HSBC halting lending to speculative funds following a $400 million hit and UBS triggering an exodus from Blue Owl (OWL) vehicles.
- UK pharmacies are bracing for a surge in demand as the oral version of the weight-loss drug Wegovy from Novo Nordisk (NVO) officially goes on sale, with 76% of pharmacists expecting a significant influx of new patients.
Aerospace and Defense Breakthroughs
China achieved a major milestone in its space program on Friday with the successful maiden flight and recovery of the Long March 10B carrier rocket. The first-stage booster was captured mid-air using a specialized "wire-net" recovery system on a vessel in the South China Sea, a method distinct from the vertical landings popularized by SpaceX (private). This development is expected to significantly lower launch costs for China's future lunar and commercial missions.
Meanwhile, Japan is preparing to test-fire its own reusable rocket prototype, the RV-X, on July 11. In the defense sector, Canaccord Genuity lowered its price target for AeroVironment (AVAV) to $240 from $280, citing uncertainties regarding multi-year supplemental war funding despite the company's strong fiscal first-quarter revenue surge of 133%.
Financial Services and Banking Innovation
Citigroup (C) has moved to disrupt traditional cross-border banking by activating 24/7 USD clearing via its proprietary Citi Token Services. The first live transaction was completed with Siam Commercial Bank, moving funds between London and Thailand over a U.S. holiday weekend. The system uses a private, permissioned blockchain to allow institutional clients to settle transactions instantly, bypassing the traditional "weekend allergy" of correspondent banking.
In the private credit market, a significant shift is underway as major lenders pull back from speculative deals. HSBC (HSBC) has reportedly informed clients it will not renew credit facilities for riskier funds following high-profile corporate bankruptcies. This follows reports that UBS (UBS) helped trigger a massive redemption wave from Blue Owl Capital (OWL) funds, as investors grow wary of weakening underwriting standards.
Global Market Performance
Asian markets saw explosive growth on Friday, led by the KOSPI, which jumped 5%. The surge was so rapid that the Korea Exchange was forced to activate a "buy-side sidecar," suspending program trading for five minutes to stabilize the market. This marks the 17th time such a mechanism has been triggered this year amid a broader AI and semiconductor-led rally.
The Singapore stock market also gained momentum, with the Straits Times Index (STI) supported by record highs from major banks including DBS (DBSDF), OCBC, and UOB. In the commodities space, iron ore is on track for its first weekly rise in a month, supported by supply constraints at BHP's (BHP) Port Hedland and ongoing port destocking.
Consumer Staples and Healthcare
JPMorgan analysts have raised their price target for Coca-Cola (KO) to $90 from $85, maintaining an "Overweight" rating. The upgrade reflects the company's strong organic revenue growth and margin expansion, which have positioned the stock as a "quality compounder" in a volatile market.
In the UK, the healthcare sector is preparing for the impact of oral Wegovy. A survey by the National Pharmacy Association found that nearly half of UK pharmacies have already seen an increase in queries. While the pill offers a more accessible alternative to injectables, 97% of pharmacists expressed concern over a potential rise in counterfeit weight-loss products on the black market.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.